Conference Activities & Talks -

Division display >> ／  All the affair displays  1 - 73 of about 73

  1. Tsuji K, Huang X, Kobayakawa T, Burke TR Jr., Tamamura H. Development of high-affinity polo-like kinase 1 polo-box domain binding peptides by bivalent approaches. The 61st Japanese Peptide Symposium 2024.10.29 Nagoya

  2. Shinohara K, Kobayakawa T, Takamatsu Y, Tsuji K, Mitsuya H, Tamamura H. Structure-activity relationship studies of novel SARS-CoV-2 papain-like protease inhibitors and their application as anti-Mpox agents. The 61st Japanese Peptide Symposium 2024.10.29 Nagoya

  3. Yamamoto K, Kobayakawa T, Tsuji K, Tamamura H. Development of chloroalkene-type dipeptide isosteres for amyloid-beta aggregation inhibitors. The 61st Japanese Peptide Symposium 2024.10.29 Nagoya

  4. Huang X, Tsuji K, KobayakawaT, Tamamura H. Investigation on degrader peptides targeting the polo-box domain for degradation of polo-like kinase 1. The 61st Japanese Peptide Symposium 2024.10.29 Nagoya

  5. Miura Y, Tsuji K, Kobayakawa T, Kuwata T, Matsushita S, Tamamura H. Development of antibody drug conjugates as HIV entry inhibitors. 37th European peptide symposium 2024.08.26 Florence

  6. Kobayakawa T, Azuma C, Yamamoto K , Tsuji K, Tamamura H. Convergent synthesis of peptidomimetic based on a chloroalkene dipeptide isostere and its application to inhibition against amyloid β aggregation. 14th International Peptide Symposium 2024.08.26 Florence, Italy

  7. Miura Y, Tsuji K, Kobayakawa T, Kuwata T, Matsushita S, Tamamura H. Development of hybrid-molecules as HIV entry inhibitors. 18th Chinese international peptide symposium 2024.07.01 Hong Kong

  8. Miura Y, Tsuji K, Kobayakawa T, Kuwata T, Matsushita S, Tamamura H. Antibody drug conjugates as HIV entry inhibitors. 27th Korean Peptide Protein Symposium 2024.06.24 Busan

  9. 山本 賢一、小早川 拓也、東 知佳、渡邉 優基、辻 耕平、玉村 啓和. アミロイドbeta凝集阻害剤を指向したクロロアルケン型ペプチドミメティックの創製. 日本薬学会第144回年会 2024.03.31 横浜

  10. 黒田 悠貴, 小早川 拓也, 辻 耕平, 紺野 奇重, 大橋 南美, 増田 亜美, 三浦 裕太郎, 桑田 岳夫, 吉村 和久, 三浦 智行, 原田 恵嘉, 松下 修三, 玉村 啓和. HIV侵入阻害剤としてのポリエチレングリコールと低分子CD4ミミックのハイブリッド化合物の創製. 日本薬学会第144回年会 2024.03.30 横浜

  11. 町田 沙穂, 小早川 拓也, 横山 勝, 藤野 真之, 金子 萌美, 倉上 真樹, 朴 清香, 大西 立人, 小谷 治, 辻 耕平, 村上 努, 佐藤 裕徳, 玉村 啓和. HIV-1カプシドタンパク質の構造を起点とした低分子型抗HIV-1剤の創製. 日本薬学会第144回年会 2024.03.30 横浜

  12. 西村 壮史, 小早川 拓也, 辻 耕平, 村上 努, 玉村 啓和. HIV-1外被タンパク質gp41を標的とする二価型膜融合阻害剤の創製. 日本薬学会第144回年会 2024.03.30 横浜

  13. 篠原 功紀，鍬田 伸好，辻 耕平，石井 貴大，小早川 拓也，服部 真一朗，岸本 直樹，高宗 暢暁，三隅 将吾，Haydar Bulut，林 宏典，満屋 裕明，玉村 啓和. SARS-CoV-2メインプロテアーゼを標的とした高抗ウイルス活性を有する低分子阻害剤の創製. 日本薬学会第144回年会 2024.03.30 横浜

  14. Takuya Kobayakawa, Chika Azuma, Kenichi Yamamoto, Kohei Tsuji, Hirokazu Tamamura. Development of synthetic strategies for peptidomimetic based on a chloroalkene dipeptide isostere and its application to a cyclic peptide. The 15th International Kyoto Conference on New Aspects of Organic Chemistry 2023.11.21 Kyoto

  15. Takuya Kobayakawa, Chika Azuma, Kenichi Yamamoto, Kohei Tsuji, Hirokazu Tamamura. Development of convergent synthesis for peptidomimetic based on a chloroalkene dipeptide isostere and its application to a cyclic peptide. The 60th Japanese Peptide Symposium 2023.11.08 Otsu

  16. Kouki Shinohara, Kohei Tsuji, Takahiro Ishii, Takuya Kobayakawa, Nobuyo Higashi-Kuwata, Yutaro Miura, Chika Azuma, Hironori Hayashi, Shin-ichiro Hattori, Haydar Bulut, Shogo Misumi, Hiroaki Mitsuya, Hirokazu Tamamura. Structure-activity relationship studies of novel SARS-CoV-2 main protease inhibitors with potent antiviral activity. The 60th Japanese Peptide Symposium 2023.11.08 Otsu

  17. Yutaro Miura, Rongyi Wang, Kohei Tsuji, Yishan Liu, Takuya Kobayakawa, Kazuhisa Yoshimura, Shuzo Matsushita, Shigeyoshi Harada, Hirokazu Tamamura. Combinational use of CD4 mimic with other anti-HIV agents and development of these hybrid molecules. 14th International Peptide Symposium 2023.10.17 Brisbane

  18. Yutaro Miura, Rongyi Wang, Kohei Tsuji, Yishan Liu, Takuya Kobayakawa, Kazuhisa Yoshimura, Shuzo Matsushita, Shigeyoshi Harada, Hirokazu Tamamura. Double target inhibitors of HIV-1 entry based on hybrid molecules of CD4 mimics and HIV-1 gp41-related peptides. 26th Korean Peptide Protein Symposium 2023.07.04 Jeju

  19. Takahiro Ishii, Kohei Tsuji, Takuya Kobayakawa, Nobuyo Higashi-Kuwata, Chika Azuma, Kouki Shinohara, Yutaro Miura, Hironori Hayashi, Haydar Bulut, Shogo Misumi, Hiroaki Mitsuya, Hirokazu Tamamura . Design and Synthesis of SARS-CoV-2 Mpro Inhibitors Containing Flurine Atoms and Amide Surrogates. 26th KPPS Annual Symposium 2023.07.03 Jeju

  20. Takahiro Ishii, Takuya Kobayakawa, Kouki Matsuda, Kohei Tsuji, Nami Ohashi, Kazuhisa Yoshimura, Hiroaki Mitsuya, Kenji Maeda, Hirokazu Tamamura . Structure-Activity Relationship Studies of DAG-lactone Derivatives with HIV-1 Latancy Reversing Activity. 14th AFMC International Medicinal Chemistry Symposium 2023.06.27 Seoul

  21. Yutaro Miura, Rongyi Wang, Kohei Tsuji, Yishan Liu, Takuya Kobayakawa, Kazuhisa Yoshimura, Shuzo Matsushita, Shigeyoshi Harada, Hirokazu Tamamura. Hybrid molecules of CD4 mimic and HIV-1 fusion inhibitors. 14th AFMC International Medicinal Chemistry Symposium 2023.06.26 Seoul

  22. Kohei Tsuji, Kofi Baffour-Awuah Owusu, Takuya Kobayakawa, Youichi Suzuki, Hirokazu Tamamura. Development of fusion inhibitor peptides of SARS-CoV-2 learned from anti-HIV-1 agents. 第59回ペプチド討論会 2022.10.26 仙台

  23. Kouki Shinohara, Kohei Tsuji, Takahiro Ishii, Takuya Kobayakawa, Nobuyo Higashi-Kuwata, Yutaro Miura, Hironori Hayashi, Shin-ichiro Hattori, Haydar Bulut, Shogo Misumi, Hiroaki Mitsuya, Hirokazu Tamamura. Structure-activity relationship studies of SARS-CoV-2 main protease inhibitors. 第59回ペプチド討論会 2022.10.26 仙台

  24. Yutaro Miura, Takuya Kobayakawa, Kohei Tsuji, Kiju Konno, Ami Masuda, Nami Ohashi, Takeo Kuwata, Kazuhisa Yoshimura, Tomoyuki Miura, Shigeyoshi Harada, Shuzo Matsushita, Hirokazu Tamamura. Pegylated CD4 mimics as HIV inhibitors. 第59回ペプチド討論会 2022.10.26 仙台

  25. Takahiro Ishii, Kohei Tsuji, Takuya Kobayakawa, Nobuyo Higashi-Kuwata, Chika Azuma, Miyuki Nakayama, Kouki Shinohara, Yutaro Miura, Hironori Hayashi, Shin-ichiro Hattori, Haydar Bulut, Shogo Misumi, Hiroaki Mitsuya, Hirokazu Tamamura. Synthesis of inhibitors targeting the main protease of SARS-CoV-2 for therapeutics of COVID-19. 第59回ペプチド討論会 2022.10.26 仙台

  26. Kohei Tsuji, Rongyi Wang, Kofi Owusu B.-A., Takuya Kobayakawa, Tsutomu Murakami, Hirokazu Tamamura. Exploration of novel class anti-HIV-1 agents derived from a viral capsid protein. 36th European and 12th International Peptide Symposium 2022.08.29 Spain

  27. 石井 貴大, 小早川 拓也, 松田 幸樹, 辻 耕平, 吉村 和久, 満屋 裕明, 前田 賢次, 玉村 啓和. HIV 感染症の根治を指向した DAG-ラクトン誘導体の構造最適化研究. 日本ケミカルバイオロジー学会 第16回年会 2022.05.31 富山

  28. 石井 貴大, 小早川 拓也, 松田 幸樹, 辻 耕平, 吉村 和久, 満屋 裕明, 前田 賢次, 玉村 啓和. HIV感染症の根治を指向したDAG-ラクトン誘導体の合成. 日本薬学会第142年会 2022.03.27 online

  29. Hirokazu Tamamura, Takuya Kobayakawa, Kento Ebihara, Tsutomu Murakami, Kohei Tsuji. Development of HIV-1 fusion inhibitors based on dimeric derivatives of the C34 peptide and its peptidomimetics. The 2021 International Chemical Congress of Pacific Basin Societies (Pacifichem 2021) 2021.12.18 online (Hawaii)

  30. Kohei Tsuji, Rongyi Wang, Kofi Baffour-Awuah Owusu, Takuya Kobayakawa, Tsutomu Murakami, Hirokazu Tamamura. Explorative study in development of anti-HIV-1 peptides based on HIV-1 capsid protein segments. The 2021 International Chemical Congress of Pacific Basin Societies (Pacifichem 2021) 2021.12.15 online (Hawaii)

  31. Takahiro Ishii, Takuya Kobayakawa, Kouki Matsuda, Kohei Tsuji, Kazuhisa Yoshimura, Hiroaki Mitsuya, Kenji Maeda, Hirokazu Tamamura. Development of protein kinase C activators for cure of HIV infectious diseases. The 2021 International Chemical Congress of Pacific Basin Societies (Pacifichem 2021) 2021.12.15 online (Hawaii)

  32. Takuya Kobayakawa, Kohei Tsuji, Kiju Konno, Ami Masuda, Nami Ohashi, Takeo Kuwata,Kazuhisa Yoshimura, Tomoyuki Miura, Shigeyoshi Harada, Shuzo Matsushita, Hirokazu Tamamura. HIV entry inhibitors based on CD4 mimics with PEG units toward cure for HIV-infectious diseases. The 13th AFMC International Medicinal Chemistry Symposium 2021.12.02 online (Tokyo)

  33. Takahiro Ishii, Takuya Kobayakawa, Kouki Matsuda, Kohei Tsuji, Kazuhisa Yoshimura, Hiroaki Mitsuya, Kenji Maeda, Hirokazu Tamamura. Structure-Activity Relationship Studies of Protein Kinase C Activators Derived from Diacylglycerol for Cure of HIV Infectious Diseases. The 13th AFMC International Medicinal Chemistry Symposium 2021.11.29 online (Tokyo)

  34. Rongyi Wang, Kohei Tsuji, Yishan Liu, Takuya Kobayakawa, Tsutomu Murakami, Hirokazu Tamamura. HYBRID MOLECULES OF CD4 MIMIC AND HIV-1 GP41-RELATED PEPTIDES AS FUSION INHIBITORS. 第58回ペプチド討論会 2021.10.22 online（Tokyo）

  35. Kohei Tsuji, Takahiro Ishii, Takuya Kobayakawa, Nami Ohashi, Wataru Nomura, Hirokazu Tamamura. A FRET-BASED ASSAY SYSTEM FOR PROTEIN KINASE C LIGAND SCREENING USING 1,2-DIACYLGLYCEROL-LACTONE DERIVATIVE. 第58回ペプチド討論会 2021.10.20 online（Tokyo）

  36. Wataru Nomura, Takumi Kamimura, Takuya Kobayakawa, Hirokazu Tamamura. Endogenous protein expression imaging by fluorogenic ZIP tag-probe system. 第57回ペプチド討論会 2020.11.10 online

  37. Kofi Baffour-Awuah Owusu, Kohei Tsuji, Rongyi Wang, Takuya Kobayakawa, Moemi Kaneko, Tsutomu Murakami, Hirokazu Tamamura. Exploratory studies on the development of anti-HIV-1 peptides based on HIV-1 capsid fragments. 第57回ペプチド討論会 2020.11.10 online

  38. Chika Azuma, Takuya Kobayakawa, Kohei Tsuji, Hirokazu Tamamura. A convergent synthesis of chloroalkene dipeptide isosteres as peptidomimetics. 第57回ペプチド討論会 2020.11.09 online

  39. Maeda Kenji, Matsuda Kouki, Islam Saiful, Kobayakawa Takuya, Tsuchiya Kiyoto, Hattori Shin-ichiro, Gatanaga Hiroyuki, Oka Shinichi, Yoshimura Kazuhisa, Tamamura Hirokazu, Mitsuya Hiroaki, Satou Yorifumi. HIV持続潜伏感染に関する最先端研究　HIV治癒に向けたlatency reversing agents(LRAs)を用いたHIV-1リザーバーの治療(Treatment of HIV-1-reservoirs using latency-reversing agents(LRAs) toward HIV cure). 日本エイズ学会誌 2019.11.01

  40. Tsutomu Murakami, Kento Ebihara, Takuya Kobayakawa, Masayuki Fujino, Eiichi Kodama, Hirokazu Tamamura. Elucidation of mechanism of HIV-1 fusion inhibitors developed by dimerization strategy. The 67th Annual Meeting of the Japanese Society for Virology 2019.10.29 Tokyo

  41. Kouki Matsuda, Takuya Kobayakawa, Kiyoto Tsuchiya, Shin-ichiro Hattori, Hiroyuki Gatanaga, Kazuhisa Yoshimura, Shinichi Oka, Yasuyuki Endo, Hirokazu Tamamura, Hiroaki Mitsuya, Kenji Maeda. Benzolactam protein kinase C activators promote apoptosis of HIV-infected human cells via HIV latency reversal. The 67th Annual Meeting of the Japanese Society for Virology 2019.10.29 Tokyo

  42. Wataru Nomura, Takumi Kamimura, Takuya Kobayakawa, Hirokazu Tamamura. Fluorogenic ZIP tag-probe system for fluorescent imaging of endogenous protein expression. The 56th Japanese Peptide Symposium 2019.10.25 Tokyo

  43. Rongyi Wang, Takuya Kobayakawa, Moemi Kaneko, Kofi Owusu, Tsutomu Murakami, Hirokazu Tamamura. Development of cell-permeable anti-HIV peptides based on capsid proteins. The 56th Japanese Peptide Symposium 2019.10.25 Tokyo

  44. Maxwell M. Sakyiamah, Wataru Nomura, Takuya Kobayakawa, Hirokazu Tamamura. Development of a nanoBRET-based sensitive screening method to search for chemokine receptor CXCR4 ligands. The 56th Japanese Peptide Symposium 2019.10.25 Tokyo

  45. Yuki Watanabe, Takuya Kobayakawa, Atsuhiko Taniguchi, Yoshio Hayashi, Hirokazu Tamamura. Development of peptidomimetic inhibitors for aggregation of amyloid beta. The 56th Japanese Peptide Symposium 2019.10.23 Tokyo

  46. Takuya Kobayakawa, Hirokazu Tamamura. Development of chemical synthesis for peptidomimetic based on a chloroalkene dipeptide isostere and its application to a cyclic peptide. The 56th Japanese Peptide Symposium 2019.10.23 Tokyo

  47. Masaki Kurakami, Takuya Kobayakawa, Masaru Yokoyama, Tsutomu Murakami, Moemi Kaneko, Osamu Kotani, Hironori Sato, Hirokazu Tamamura. Structure-activity relationship studies of small molecular anti-HIV-1 compounds targeting a dipeptide site of HIV-1 capsid proteins. The 56th Japanese Peptide Symposium 2019.10.23 Tokyo

  48. Kento Ebihara, Yuzuna Honda, Takuya Kobayakawa, Tsutomu Murakami, Hirokazu Tamamura. Development of HIV-1 fusion inhibitors based on the C34 dimer derived from an HIV-1 envelope protein gp41. The 56th Japanese Peptide Symposium 2019.10.23 Tokyo

  49. Wataru Nomura , Takumi Kamimura, Daisuke Matsumoto, Takuya Kobayakawa, Hirokazu Tamamura. Fluorogenic and genetically encodable tag-probe system for in-cell imaging of protein synthesis . 10th International Peptide Symposium 2018.12.05 Kyoto, Japan

  50. Takuya Kobayakawa, Hirokazu Tamamura. Synthetic Strategy of Peptidomimetic Based on Chloroalkene Dipeptide Isoteres and Its Biological Application. 10th International Peptide Symposium 2018.12.03 Kyoto, Japan

  51. Kento Ebihara, Yuzuna Honda, Takuya Kobayakawa, Tsutomu Murakami, Hirokazu Tamamura. HIV-1 Fusion Inhibitors Based on gp41-C34 dimers. 10th International Peptide Symposium 2018.12.03 Kyoto, Japan

  52. Takuya Kobayakawa, Kohei Takahashi, Ami Masuda, Shigeyoshi Harada, Tomoyuki Miura, Shuzo Matsushita, Kazuhisa Yoshimura, Hirokazu Tamamura. Structure‐activity relationship studies of CD4 mimic molecules for targeting an envelope protein gp120 on HIV-1. 19th Kumamoto AIDS Seminar 2018.11.06 Kumamoto, Japan

  53. Takuya Kobayakawa, Kohei Takahashi, Ami Masuda, Shigeyoshi Harada, Tomoyuki Miura, Shuzo Matsushita, Kazuhisa Yoshimura, Hirokazu Tamamura. Structure‐activity relationship studies of CD4 mimic molecules for targeting an envelope protein gp120 on HIV-1. 19th Kumamoto AIDS Seminar 2018.11.06 Kumamoto, Japan

  54. Tsutomu Murakami, Kento Ebihara, Masayuki Fujino, Yuzuna Honda, Takuya Kobayakawa, Wataru Nomura, Hirokazu Tamamura. Development of new membrane fusion inhibitors against HIV-1 by “dimerization” strategy. The 66th Annual Meeting of the Japanese Society for Virology 2018.10.28 Kyoto, Japan

  55. Maxwell M. Sakyiamah, Wataru Nomura, Takuya Kobayakawa, Hirokazu Tamamura. Development of a new NanoBRET assay system for CXCR4 ligands and their Structure-activity relationship studies. Frontiers 2018 Symposium (EPFL/TMDU/UTokyo Joint Symposium) 2018.09.21 Lausanne, Switzerland

  56. Maxwell Mamfe Sakyiamah, Wataru Nomura, Takuya Kobayakawa, Hirokazu Tamamura. Development of NanoBRET assay system in living cells for structure-activity relationship studies of CXCR4 ligands. The 62nd Annual Meeting of the Pharmaceutical Society of Japan Kanto Branch 2018.09.15 Tokyo, Japan

  57. 小早川 拓也. “化学”から“薬”の開発へ. 2018年度 国立大学法人 東京医科歯科大学 オープンキャンパス サイエンスカフェ（最新医歯学研究）～研究者の話を聞こう～ 2018.07.27 東京, 日本

  58. Maxwell M. Sakyiamah, Wataru Nomura, Takuya Kobayakawa, Hirokazu Tamamura. Development of NanoBRET assay system in living cells to search potent CXCR4 ligands. The 13th Annual Meeting of Japanese Society for Chemical Biology 2018.06.13 Tokyo, Japan

  59. Tsutomu Murakami, Masayuki Fujino, Masaru Yokoyama, Takuya Kobayakawa, Hiroaki Takeuchi, Takao Masuda, Osamu Kotani, Hirokazu Tamamura, Hironori Sato. Biological and molecular characterization of a novel anti-HIV-1 compound created by in silico design and de novo organic synthesis. Cold Spring Harbor Laboratory Meetings & Courses, Retrovirus Meeting 2018.05.23 Cold Spring Harbor, United States of America

  60. Maxwell M. Sakyiamah, Wataru Nomura, Hirokazu Tamamura. Development of a sensitive screening method to search potent ligands of CXCR4. 138th Annual Meeting of the Pharmaceutical Society of Japan 2018.03.26 Ishikawa, Japan

  61. Wataru Nomura, Daisuke Matsumoto, Taisuke Sugii, Takuya Kobayakawa, Hirokazu Tamamura. Differential regulation of endogenous genes in an orthogonal manner by distinct chemically inducible systems. International Conference on Epigenetics and Bioengineering 2017.12.13 Miami, United States of America

  62. Kouki Matsuda, Shin-ichiro Hattori, Kiyoto Tsuchiya, Takuya Kobayakawa, Ohashi Nami, Wataru Nomura, Shigeyoshi Harada, Yorifumi Sato, Kazuhisa Yoshimura, Hirokazu Tamamura, Hiroaki Mitsuya, Kenji Maeda. Development of novel therapeutics to eliminate latently infected cells by LRAs toward HIV cure. 18th KUMAMOTO AIDS Seminar 2017.10.31 Kumamoto, Japan

  63. Ami Masuda, Shigeyoshi Harada, Shokichi Takahama, Kohei Takahashi, Kiju Konno, Takuya Kobayakawa, Ai Himeno, Tomoyuki Miura, Takeo Kuwata, Shuzo Matsushita, Kazuhisa Yoshimura, Hirokazu Tamamura. Development of CD4 mimics for enhancement of activity of HIV neutralizing antibodies. 18th KUMAMOTO AIDS Seminar 2017.10.31 Kumamoto, Japan

  64. Nami Ohashi, Shigeyoshi Harada, Yu Irahara, Yusuke Ishida, Kiju Konno, Takuya Kobayakawa, Wataru Nomura, Shuzo Matsushita, Kazuhisa Yoshimura, Hirokazu Tamamura. CD4 Mimics for Enhancement of Activity of HIV Neutralizing Antibodies. The 11th AFMC International Medicinal Chemistry Symposium 2017.07.24 Melbourne, Australia

  65. Takuya Kobayakawa, Hirokazu Tamamura. Development of Synthetic Methods for Chloroalkene Dipeptide Isosteres and Their Applications. The 25th American Peptide Symposium and the 9th International Peptide Symposium 2017.06.19 Whistler, Canada

  66. Takuya Kobayakawa, Yudai Matsuzaki, Wataru Nomura, Kentaro Hozumi, Motoyoshi Nomizu, Hirokazu Tamamura. Development of Chloroalkene Dipeptide Isosteres as Peptidomimetics and Their Application. The 2nd Peptides and Proteins Society of Singapore Symposium 2016.12.08 Nanyang Technological University, Singapore

  67. Takuya Kobayakawa, Hirokazu Tamamura. Development of synthetic methodology of chloroalkene-type dipeptide isosteres for peptidomimetics. 252nd American Chemical Society National Meeting 2016.08.23 Pennsylvania, United States of America

  68. Tetsuo Narumi, Takuya Kobayakawa, Hirokazu Tamamura. Highly Diastereoselective Synthesis of (Z)-Chloroalkene Dipeptide Isosteres by Remote Stereoinduction in the Organocuprate-Mediated Allylic Alkylation of Allylic gem-Dichlorides. Molecular Chirality Asia 2016 2016.04.20 Osaka, Japan

  69. Takuya Kobayakawa, Hirokazu Tamamura. Development of Chloroalkene Dipeptide Isosteres as Peptidomimetic Based on the Ground State of Peptide Bonds. 第8回武田科学振興財団薬科学シンポジウム 生命分子から薬を創る －中分子薬を中心に－ 2016.01.26 大阪, 日本

  70. Takuya Kobayakawa, Hirokazu Tamamura. Development of Synthetic Methods for Chloroalkene Dipeptide Isosteres as Peptidomimetic Based on the Ground State of Amide Bonds. The 7th International Peptide Symposium 2015.12.09 Matrix Biopolis, Singapore

  71. 小早川 拓也. 多種のクロロアルケン型ジペプチドイソスターの合成法の開発. 13th IBB BioFuture Research Encouragement Prize研究発表会 2015.01.30 東京, 日本

  72. Takuya Kobayakawa, Tetsuo Narumi, Hirokazu Tamamura. Development of Efficient Synthetic Methodologies of Chloroalkene Dipeptide Isosteres. 第51回ペプチド討論会 2014.10.22 徳島, 日本

  73. Tetsuo Narumi, Takuya Kobayakawa, Hirokazu Tamamura. Design and Synthesis of Chloroalkene Dipeptide Isosteres as Ground State Peptidomimetics. The 10th Australian Peptide Conference 2013.09.08 Penang, Malaysia

< PREV - NEXT >

  • 1
To the head of this page.▲